Industry Recommendations and Suggestions for the Practical Implementation of Policy Principles to Improve Access to Orphan Medicinal Products in the EU

27.11.2009

Industry Recommendations and Suggestions for the Practical Implementation of Policy Principles  to Improve Access to Orphan Medicinal Products in the EU 

The EU’s Orphan Regulation 141/2000 has been a success in stimulating the research and development of orphan medicinal products. However, it has been acknowledged that, despite the approvals for new treatments for orphan conditions, equitable and timely access to these approved treatments remains an issue in the EU.

 

Latest Position papers